Diabetes, Obesity and Metabolism Now10.1002/doi2.000262020COVID‐19: An opportunity to make long‐term improvement changes to inpatient diabetes servicesIskandar Idris,,
Diabetes, Obesity and Metabolism Now10.1002/doi2.000182020Study dissecting COVID‐19 related mortality in people with Type 1 and Type 2 diabetesIskandar Idris,,
The Journal of Korean Diabetes10.4093/jkd.2021.22.3.1742021223174-178Diabetes, Obesity, and COVID-19Sang Youl Rhee,,
Diabetes, Obesity and Metabolism Now10.1002/doi2.000162020ACE and ARB does not increase the risk of dying from COVID‐19Iskandar Idris,,
Diabetes Care10.2337/dci21-000320214491929-1933Diabetes, Obesity, COVID-19, Insulin, and Other Antidiabetes DrugsParesh Dandona, Husam Ghanim,
Diabetes, Obesity and Metabolism10.1111/dom.14134202022101892-1896Diabetes, obesity and COVID ‐19: A complex interplayPrashanth Vas, David Hopkins, Michael Feher, Francesco Rubino, Martin Whyte,,,
The Lancet Diabetes & Endocrinology10.1016/s2213-8587(20)30274-6202089731Obesity and COVID-19: Blame isn't a strategy The Lancet Diabetes & Endocrinology,
Obesity Medicine10.1016/j.obmed.2021.100374202128100374Increased global online interest in diabetes during the COVID-19 pandemic: An infodemiology studyOurlad Alzeus G. Tantengco,
Diabetes, Obesity and Metabolism10.1111/dom.147462022A comment on metformin and COVID ‐19 with regard to “Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID ‐19 patients with diabetes: A population‐based study in Lombardy”Abdallah Al‐Salameh, Nicolas Wiernsperger, Bertrand Cariou, Jean‐Daniel Lalau,,
Journal of Diabetes & Metabolic Disorders10.1007/s40200-020-00682-220201922027-2030COVID-19: a one-way ticket to a global childhood obesity crisis?Sarah Cuschieri, Stephan Grech,,